CurrentRheuma
Get Weekly

Topic · page 23 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 881–920 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. Arthritis Res Ther

    Rheumatoid arthritis disease activity significantly impacts on the severity of interstitial lung disease

    Cross-sectional study

  2. Arthritis Care Res (Hoboken)

    Risk of Neuroinflammatory Diseases Among New Recipients of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs

    Cohort study

  3. J Rheumatol

    Interpersonal Process of Dyadic Coping in Rheumatoid Arthritis: A Perspective From the Australian Rheumatology Association Database

    Cross-sectional study

  4. J Rheumatol

    Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study

    Cohort study

  5. J Rheumatol

    Circulating Interleukin 17A and Other Inflammatory Proteins May Predict Cardiovascular Disease in Early Rheumatoid Arthritis

    Cohort study

  6. Arthritis Rheumatol

    Synovial 5‐Lipoxygenase–Derived Oxylipins Define a Lympho‐Myeloid–Enriched Synovium

    Cross-sectional study

  7. RMD Open

    Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study

    Secondary analysis

  8. Rheumatology (Oxford)

    Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis

    Secondary analysis

  9. Arthritis Rheumatol

    Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients

    Secondary analysis

  10. Arthritis Res Ther

    Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study

    Cohort study

  11. J Rheumatol

    Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)

    Randomized controlled trial

  12. RMD Open

    Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study

    Research article

  13. RMD Open

    Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis

    Cohort study

  14. RMD Open

    Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

    Secondary analysis

  15. Ann Rheum Dis

    Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis

    Cohort study

  16. Ann Rheum Dis

    Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis

    Mechanistic study

  17. RMD Open

    Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test

    Cohort study

  18. Rheumatology (Oxford)

    Deep learning enables automatic detection of joint damage progression in rheumatoid arthritis—model development and external validation

    Diagnostic or prognostic study

  19. RMD Open

    Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial

    Randomized controlled trial

  20. RMD Open

    Work-related physical strain and development of joint inflammation in the trajectory of emerging inflammatory and rheumatoid arthritis: a prospective cohort study

    Cohort study

  21. Arthritis Rheumatol

    Expansion of HLA‐DR Positive Peripheral Helper T and Naive B Cells in Anticitrullinated Protein Antibody‐Positive Individuals At Risk for Rheumatoid Arthritis

    Mechanistic study

  22. Joint Bone Spine

    Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis

    Cohort study

  23. Lancet Rheumatol

    Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial

    Randomized controlled trial

  24. Rheumatology (Oxford)

    Responsiveness and sensitivity of PROMs to change in disease activity status in early and established rheumatoid arthritis

    Secondary analysis

  25. RMD Open

    Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register

    Cohort study

  26. RMD Open

    Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

    Secondary analysis

  27. Rheumatology (Oxford)

    Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies

    Randomized controlled trial

  28. Rheumatology (Oxford)

    Rheumatoid arthritis patients’ perspective on the use of prediction models in clinical decision-making

    Research article

  29. Semin Arthritis Rheum

    Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

    Cohort study

  30. Arthritis Care Res (Hoboken)

    Effect of a Billing Code to Reimburse Nurse‐Supported Rheumatology Care on Health Care Costs and Access: An Interrupted Time Series Analysis

    Cohort study

  31. Rheumatology (Oxford)

    Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis

    Mechanistic study

  32. JAMA

    Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis

    Guideline or statement

  33. RMD Open

    Medication utilisation trends during pregnancy and factors influencing adverse pregnancy outcomes in patients with rheumatoid arthritis

    Cohort study

  34. Arthritis Care Res (Hoboken)

    Development of a Machine Learning Model to Predict the Use of Surgery in Patients With Rheumatoid Arthritis

    Diagnostic or prognostic study

  35. RMD Open

    Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis

    Cross-sectional study

  36. Arthritis Res Ther

    Sensitive B-cell receptor repertoire analysis shows repopulation correlates with clinical response to rituximab in rheumatoid arthritis

    Cohort study

  37. RMD Open

    Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial

    Randomized controlled trial

  38. Arthritis Res Ther

    Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort

    Cohort study

  39. Arthritis Rheumatol

    Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders

    Cohort study

  40. RMD Open

    Impact of filgotinib on pain control in the phase 3 FINCH studies

    Secondary analysis

All 1,564 Briefs in ExploreShowing Briefs 881–920 of 1,564, newest first